Boston Scientific
864 hedge funds and large institutions have $51.5B invested in Boston Scientific in 2022 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 333 increasing their positions, 294 reducing their positions, and 85 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 333 | Existing positions reduced: 294
7% more capital invested
Capital invested by funds: $48.1B → $51.5B (+$3.37B)
5% more funds holding in top 10
Funds holding in top 10: 21 → 22 (+1)
2.05% more ownership
Funds ownership: 91.26% → 93.31% (+2.1%)
4% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 85
8% less call options, than puts
Call options by funds: $232M | Put options by funds: $252M
2% less funds holding
Funds holding: 878 → 864 (-14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$909M |
| 2 |
Amundi
Paris,
France
|
+$207M |
| 3 |
Goldman Sachs
New York
|
+$203M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$167M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
+$85.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
-$585M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$116M |
| 3 |
Neuberger Berman Group
New York
|
-$79.5M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$70M |
| 5 |
Two Sigma Advisers
New York
|
-$58.9M |
BSX Hedge Fund Activity: Q3 2022 in Review
864 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2022, worth a combined $51.5B — up 7% from $48.1B a quarter earlier.
Sellers outnumbered buyers: 85 funds closed out of BSX and 82 opened new positions — a net loss of 3 holders — while 294 trimmed existing stakes and 333 added.
The largest buyer was Janus Henderson Group, adding an estimated $909M. The largest seller was Parnassus Investments, exiting entirely with an estimated $585M sold.
- 864 institutional investors held Boston Scientific (BSX) as of Q3 2022, down from 878 in Q2 2022.
- Funds reported $51.5B of Boston Scientific stock for Q3 2022, up 7% quarter-over-quarter.
- 82 funds opened new Boston Scientific positions in Q3 2022 and 85 closed out, a net change of -3 holders.
- The largest Boston Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $909M added.
- The largest Boston Scientific seller in Q3 2022 was Parnassus Investments, an estimated $585M sold.
Based on aggregated 13F filings for Q3 2022.